Stock Events

Stock Events

Barinthus Biotherapeutics.

$0.6114

0

-$0.00-0.62% Tuesday 03:42

Statistics

Day High

0.6114

Day Low

0.5662

52W High

0.7516

52W Low

0.5936

Volume

1,718

Avg. Volume

-

Mkt Cap

24.98M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Financials

-Profit Margin

Unprofitable

2021

2022

2023

2024

2025

0Revenue

-66.43MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BRNS.BOATS. It's not an investment recommendation.

Clover Health Investments

Kiora Pharmaceuticals

Milestone Scientific

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Vertex Pharmaceuticals

Vertex Pharmaceuticals focuses on developing treatments for cystic fibrosis and other serious diseases, directly competing in the same therapeutic areas as Barinthus Biotherapeutics.

Gilead Sciences

Gilead Sciences is a biopharmaceutical company that develops and markets therapies for life-threatening diseases, overlapping with Barinthus Biotherapeutics' focus areas.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of pharmaceutical products for the treatment of serious medical conditions, similar to Barinthus Biotherapeutics.

Amgen is a global biotechnology company that develops innovative human therapeutics, with a product portfolio that competes with Barinthus Biotherapeutics in several key areas.

Biogen focuses on neurology, autoimmune disorders, and rare diseases, competing with Barinthus Biotherapeutics in the biopharmaceutical sector.

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals works on RNAi therapeutics, a novel technology that competes with Barinthus Biotherapeutics' innovative approaches to drug development.

Biomarin Pharmaceutical

BioMarin Pharmaceutical focuses on rare genetic diseases, competing with Barinthus Biotherapeutics in targeting niche and underserved medical conditions.

Novartis is a large pharmaceutical company with a broad range of products that compete across several of Barinthus Biotherapeutics' key strategic areas.

Pfizer is a global pharmaceutical corporation with a diverse portfolio, including areas that overlap with the therapeutic focus of Barinthus Biotherapeutics.

About

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.

Show more...

CEO

ISIN

US91864C1071

Listings

0 Comments

Share your thoughts

FAQ

What is Barinthus Biotherapeutics. stock price today?▼

The current price of BRNS.BOATS is $0.61 USD — it has decreased by -0.62% in the past 24 hours. Watch Barinthus Biotherapeutics. stock price performance more closely on the chart.

What is Barinthus Biotherapeutics. stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Barinthus Biotherapeutics. stocks are traded under the ticker BRNS.BOATS.

What is Barinthus Biotherapeutics. market cap?▼

Today Barinthus Biotherapeutics. has the market capitalization of 24.98M

What is Barinthus Biotherapeutics. revenue for the last year?▼

Barinthus Biotherapeutics. revenue for the last year amounts to 0 USD.

What is Barinthus Biotherapeutics. net income for the last year?▼

BRNS.BOATS net income for the last year is -66.43M USD.

In which sector is Barinthus Biotherapeutics. located?▼

Barinthus Biotherapeutics. operates in the Other sector.

When did Barinthus Biotherapeutics. complete a stock split?▼

Barinthus Biotherapeutics. has not had any recent stock splits.